Diabetic Retinopathy and Calcium Dobesilate Waldorf MD

Read more about Diabetic Retinopathy and Calcium Dobesilate.

Tri-County Chiropractic and Spinal Rehabilita
(301) 645-5390
3261Old Washington Rd
Waldorf, MD

Data Provided by:
St. Charles Animal Hospital
(301) 645-2550
11685 Doolittle Drive
Waldorf, MD

Data Provided by:
MOHAMMED YOUSHAUDDIN
(301) 856-2810
9131 Piscataway Rd.
Clinton, MD
Specialties
Nephrology, INTERNAL MEDICINE
Insurance
Insurance Plans Accepted: MOST INSURANCE PLANS ACCEPTED
Medicare Accepted: Yes

Doctor Information
Residency Training: University of Illinois at Chicago
Medical School: Univ of Health Sciences - India, 1997
Additional Information
Member Organizations: AMERICAN SOCIETY OF NEPHROLOGY AMERICAN SOCIETY OF HYPERTENSION


Data Provided by:
Lake Forest Clinic
(301) 787-8556
Oxon Hill, MD

Data Provided by:
Coolridge Animal Hospital
(301) 449-1610
6801 Old Branch Ave.
Camp Springs, MD

Data Provided by:
Life Care Chiro & Wellness Center
(301) 870-4277
1 Post Office Rd # 102
Waldorf, MD

Data Provided by:
David A Spott, MD
(301) 868-7077
9131 Piscataway Rd
Clinton, MD
Business
David A Spott MD
Specialties
Dermatology

Data Provided by:
Rosa Rehab
(240) 619-7807
4269 Branch Ave
Temple Hills, MD

Data Provided by:
Dr. Brian Bodnar
(703) 721-0500
6969 Richmond Highway
Alexandria, VA
Business
Bodnar Chiropractic Center
Specialties
Chiropractic, acupuncture, massage therapy, herbal medicine, traditional chinese medicine, reflexology, decompression therapy
Insurance
Insurance Plans Accepted: Aetna, Cigna, Great West, United Healthcare, Mailhandlers, Blue Cross Blue Shield, Blue Cross Federal, Medicare and we bill any insurance with coverage.
Medicare Accepted: Yes
Workmens Comp Accepted: Yes
Accepts Uninsured Patients: Yes
Emergency Care: Yes

Doctor Information
Residency Training: Rock Island
Medical School: Palmer College of Chiropractic, 1997
Additional Information
Languages Spoken: English

Data Provided by:
Triandos Chiropractic and Accupuncture
(703) 548-5600
312 S Washington St Ste. 4D
Alexandria, VA

Data Provided by:
Data Provided by:

Diabetic Retinopathy and Calcium Dobesilate

Diabetic Retinopathy and Calcium Dobesilate.
Date: Wednesday, May 27, 2009
Source: The Lancet
Related Monographs: Diabetes Mellitus, Type 2
Natural Health Information that is accurate, objective, science-based and represents the current state of research is the most sought-after information category today. Natural Health Information On Demand, NHIOndemand, is the leading source for this valuable science-based natural health information.
©2000-2009 CCG, Inc. All Rights Reserved.

Diabetic retinopathy is retinopathy (damage to the retina) caused by complications of diabetes mellitus, which can eventually lead to blindness.  It is the most common diabetic eye disease and affects up to 80% of all patients who have had diabetes for 10 years or more. Small blood vessels - such as those in the eye - are especially vulnerable to poor blood sugar (blood glucose) control which could cause an over accumulation of glucose and/or fructose damaging the tiny blood vessels in the retina. During the initial stage, called nonproliferative diabetic retinopathy (NPDR), most people do not notice any change in their vision. In the United States, diabetic retinopathy is the leading cause of blindness in adults. All people with diabetes mellitus are at risk - those with type 1 diabetes (juvenile onset) and those with type 2 diabetes (adult onset). Between 40 to 45 percent of Americans diagnosed with diabetes have some stage of diabetic retinopathy.

Calcium dobesilate, also known as 2,5-dihydroxybenzene sulfonate, is a drug commonly used in the treatment of diabetic retinopathy and chronic venous insufficiency. The pharmacology of calcium dobesilate reveals its ability to decrease capillary permeability, as well as platelet aggregation (clumping together of platelets) and blood viscosity (a measure of the resistance of blood to flow).

A multi-center randomized, double-blind and placebo controlled study assessed the effect of calcium dobesilate on the occurrence of diabetic macular edema. The study, which took place in 40 different centers in 11 countries, enrolled 635 patients with type 2 diabetes and mild-to-moderate non-proliferative diabetic retinopathy. The patients were then randomly selected to receive either calcium dobesilate or a placebo. Clinically significant macular edema (CSME) developed in 86 of the 324 people who took calcium dobesilate and in 69 of the 311 who took the placebo. It was determined that people who took the drug were 32 percent more likely to develop CSME than those who took the placebo. This information suggests that calcium dobesilate could neither prevent the occurrence of macular edema nor reduce the probability of developing it. The researchers concluded that the best way to prevent diabetic blindness is by implementing systemic screenings for diabetic retinopathy and preventive laser treatment for those who develop macular edema or proliferative retinopathy.1  

1 Haritoglou C, Gerss J, Sauerland C, et al. Effect of calcium dobesilate on occurrence of diabetic macular oedema (CALDIRET study): randomised, double-blind, placebo-controlled, multicentre trial. The Lancet. 2009;373(9672):1364-1371.

This information is educational in context and is not to be used to diagnose, treat or cure any disease. Please consult your licensed health care practitioner before using this or any medical information.
©2000-2009 CCG, Inc. All Rights Reserved.